Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eltel publishes Annual Report 2021

Eltel’s Annual Report 2021, which also includes the Sustainability Report, is now available at https://www.eltelgroup.com/investors/financial-reports-and-presentations/.Printed copies, in Swedish and English, are available as from week 16, and can be ordered at https://www.eltelgroup.com/media/order-printed-material/. For further information, please contact: Elin Otter, Director and Head of Group Communications and Investor Relations Phone: +46 72 59 54 692, elin.otter@eltelnetworks.com This information is information that Eltel AB is obliged to make public pursuant to the

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (BlackRock, Inc.)

Nordea Bank AbpStock exchange release – Major shareholder announcements30 March 2022 at 10.00 EET Nordea Bank Abp has on 29 March 2022 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of 5 per cent on 28 March 2022. The total number of shares and voting rights in Nordea Bank Abp is 3,860,317,333. Total positions of BlackRock, Inc. and its funds according to the notification: +----------------+--------------

SmartCraft (SMCRT) will present at Redeye Saas Seminar 2022

SmartCraft ASA | Non-regulatory press releases 30 March 2022 - SmartCraft, the leading Nordic provider of mission-critical SaaS solutions to SME's in the construction sector, will present at Redeye Saas Seminar 2022. On April 6th at 14:15 CET, CEO Gustav Line will present the latest developments in the company at Redeye. The presentation is live broadcasted and can be followed at https://www.redeye.se/events/830738/redeye-saas-seminar-spring-2022 where the replay and the presentations will be available afterwards.  Contacts Gustav LineCEOTel: +47 952 67 104 gustav.line@

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 29th March 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,539,886 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Notice of Annual General Meeting of Projektengagemang Sweden AB (publ)

The shareholders of Projektengagemang Sweden AB (publ), reg. no. 556330–2602, (”Projektengagemang” or ”Company”), are hereby given notice of the Annual General Meeting (“AGM”) on Thursday, 5 May 2022.The Board of Directors has decided that the meeting 2022 should be held without physical presence of shareholders, representatives or third parties. The shareholders are entitled to exercise their voting rights only by post prior to the meeting. Information of the resolutions that the meeting will resolve will be disclosed after the meeting. A recording with CEO Helena Hed will be available

Carbiotix starts evaluation project with Nordic contract manufacturing company that produces plant based dairy alternatives

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has started a ninemonth evaluation project with a Nordic contract manufacturing company that produces plant based dairy alternatives. The initial evaluation study conducted in the first quarter of 2022 demonstrated positive results to produce CarbiAXOS from a side-stream fibre product in the production of plant based dairy alternatives. This project will therefore evaluate, in detail, the technical and economic feasibility of scaling up CarbiAXOS production using the same fibre. The project will serve as a business

Idogen signs strategic collaboration agreement with contract research companies

Idogen AB (publ) has signed a strategic collaboration agreement with two contract research organizations (CRO), Klifo and 4Pharma, which will together with Idogen run the clinical phase 1/2a study with IDO 8, a new cell therapy for patients with severe hemophilia who have developed antibodies to their treatment with coagulation factor VIII. The collaboration agreement applies to all testing centers in Europe where the study will be conducted.   Idogen's tolerogenic cell therapy treatment IDO 8 aims to create tolerance for factor VIII and thus enable ongoing substitution treatment with

Lippulaiva, representing the future of mixed-use, urban centres, opens its doors in Espoonlahti

CITYCON OYJ Corporate Press Release 30 March 2022 Lippulaiva, the new mixed-use centre representing the future of convenient urban living, will open its doors tomorrow on 31 March in Espoonlahti near Helsinki. Lippulaiva will be the first stop in the community for local services and an important strategic milestone in the implementation of Citycon's mixed-use development plans. The services for the residents of the Espoonlahti area will be greatly improved when Lippulaiva opens its doors on Thursday, 31 March. Lippulaiva will be a thriving urban centre for local services in its

Toivo Group Plc concludes an agreement for a 74-apartment project in Espoon Keskus

Press release, 30 March 2022 at 9:30 a.m. Toivo Group Plc (hereinafter referred to as “Company” or “Toivo”) has concluded a project agreement valued at about EUR 14.5 million in Espoon Keskus. The project includes an existing residential building with 38 apartments as well as a permit for the construction of about 36 new apartments and business premises. The permit planning of the new building has been started and the construction is set to begin in early 2023. The planning and design will follow Toivo’s environmentally friendly and customer-oriented principles.  “The project is

Publication of Biohit Oyj Annual Report 2021

Biohit Oyj Annual Financial Report March 30, 2022 at 09:30 am local time (EET)   Biohit Oyj’s Annual Report 2021 is published today in PDF format. The annual report contains financial statements for 2021, the Report of the Board of Directors and Corporate Governance Statements. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website: Annual Reports - Biohit Healthcare  

Annual Report 2021

Vitrolife has today published its Annual Report for 2021. The document is attached to this press release and is also available on www.vitrolife.com.Distribution of the printed versions of the Annual Reports to those shareholders who have requested dispatch, will be done by mail during the week commencing 11 April. The printed version of the Annual Report can be ordered on the company's website www.vitrolife.com, by phone +46 (0)31 721 80 00 or by email info@vitrolife.com. Gothenburg, SwedenMarch 30, 2022VITROLIFE AB (publ)

Klaria Pharmaceuticals enters into Agreement with FluiMed GmbH to develop Sirolimus Alginate Film for prevention of Organ Transplant Rejection

Uppsala, 30 March, 2020.  Sirolimus has an immunosuppressant  function and is used to prevent the rejection of organs in Solid Organ Transplantation (SOT) procedures.  However, both the efficacy and safety of Sirolimus varies greatly between individual patients.  This variability is due to how the treatment is metabolized.  An Alginate Film that delivers Sirolimus directly into the blood stream via the oral mucosa would not be subject to this variability.  The result would be a treatment that would make life-saving Solid Organ Transplant

Tele2’s Annual and Sustainability Report 2021

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today published its Annual and Sustainability Report 2021, which is available at www.tele2.com.Highlights from the Annual Report 2021 · Continued execution of our more-for-more strategy in Sweden B2C, turnaround of the Sweden B2B business and strong performance in the Baltics driven by our mobile centric convergence strategy. · Acquired spectrum in Sweden and Latvia necessary to build nationwide 5G-networks. · Mid-term strategy presented at the Capital Markets Day in May 2021. · Consolidated Tele2 and Com Hem

Björn Züger appointed as new President and CEO of Loomis USA

Björn Züger has been appointed as the new President and CEO of Loomis USA, effective at the latest as of 1 August 2022. Currently, Björn is serving as Country President of Loomis Switzerland and Regional Vice President for Austria/Germany/Switzerland. Björn will report to the Loomis group’s President and CEO and be a member of the group management team.   Björn Züger is a Swiss citizen born in 1970. He has attended business schools in Switzerland, specializing within logistics and supply chain management. Björn has previously held various management positions within the VIA MAT Group

FluoGuide A/S publishes Year-end and annual report for the fiscal year 2021

Copenhagen, Denmark, 30 March 2022  – FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year 2021. The annual report including the auditor’s report is attached as a pdf. The report is also available on FluoGuide’s website www.fluoguide.com under ‘Filings & reports’. https://fluoguide.com/investor/filings-reports/KEY FINANCIAL FIGUES Q4 2021 Summary Q4 2021 Q4 2020 Q1-Q4 2021 Q1-Q4 2020 01-okt-21 01-okt-21 01-jan-21 01-jan-20(KDKK) 31-dec-21 31-dec-21 31-dec-

Jonas Wallmander appointed as new CEO of Azelio

The Board of Directors of Azelio AB has appointed Jonas Wallmander as its new Chief Executive Officer. Jonas Wallmander joined Azelio in 2011 and has been Executive Vice President and part of the Executive Team since 2017. He assumes his new position with immediate effect, replacing Jonas Eklind.   Jonas Wallmander has worked in the energy sector since 2005 where he has gained extensive know-how in the field of renewable energy. He was initially recruited to Azelio in 2011 as Chief Operating Officer (then known as Cleanergy), and over the years he has been responsible for large

Quarterly Report II 21/22

September 2021 – February 2022, Diamyd Medical AB (publ), Fiscal year 2021/2022Developing Precision Medicine Therapies for Type 1 DiabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period (parent company) previous financial year. September 1, 2021 – February 28, 2022 · Net result: MSEK -46.5 (120.0), second quarter: MSEK -9.0 (-15.1). The previous year contains a one-off effect of corresponding MSEK 144.4 from

Aker Clean Hydrogen AS: Notice of postponed Annual General Meeting with amended agenda

Reference is made to the recently announced contemplated merger (the “Merger”) between Aker Clean Hydrogen AS (the “Company”) and AH Seksten AS, a subsidiary of Aker Horizons ASA (“AKH”). The Merger is subject to the approval of the Company’s general meeting. To avoid holding two general meetings within a short time period, the board of directors have decided to postpone the Company’s annual general meeting originally scheduled for 19 April 2022, until 4 May 2022 at 12.00 (CEST), and amend the agenda for the general meeting to also include the approval of the Merger. Please find attached

Aker Offshore Wind AS: Notice of Postponed Annual General Meeting with Amended Agenda

Reference is made to the recently announced contemplated merger (the “Merger”) between Aker Offshore Wind AS (the “Company”) and AH Tretten AS, a subsidiary of Aker Horizons ASA (“AKH”). The Merger is subject to the approval of the Company’s general meeting. To avoid holding two general meetings within a short time period, the board of directors have decided to postpone the Company’s annual general meeting originally scheduled for 19 April 2022, until 4 May 2022 at 14.00 (CEST), and amend the agenda for the general meeting to also include the approval of the Merger.Please find attached the

Aker Horizons ASA: Updated proposed resolutions by the board of directors to the 2022 AGM

Reference is made to the stock exchange announcement made by Aker Horizons ASA (the “Company” or “Aker Horizons”) of 22 March 2022 giving notice of the annual general meeting to be held on 22 April 2022 (the “AGM”) and the recently announced contemplated take-private mergers (the “Mergers”) with Aker Offshore Wind AS and Aker Clean Hydrogen AS whereby Aker Horizons will issue merger consideration shares.The Mergers are not subject to approval by the Company’s general meeting as the Company is not a direct party to the Mergers and will only issue consideration shares. The Company plans to

Notice of Annual General Meeting

The Annual General Meeting of Targovax ASA (the "Company") will be held at the Company’s offices at Lysaker, on 20 April 2022 at 16:00 CET. Notice of attendance Notice of attendance must be received no later than 19 April 2022 at 16:00 CET. Casting of advance votes and submission of proxies must be received no later than 19 April 2022 at 16:00 CET. Attached you will find the notice to the General Meeting, including appendices. The notice and appendices will also be made available on Targovax’ website https://www.targovax.com/en/section/governance/general-meetings/. TRVX -

Alzinova improves manufacturing process of ALZ-101 to meet phase 2 requirements

Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing disease-modifying treatments for Alzheimer’s, today announces that the manufacturing process for its oligomer-specific vaccine, ALZ-101, has been further improved to facilitate large-scale production.Alzinova’s drug substance manufacturing partner, Bachem (Bubendorf, Switzerland), has optimised the manufacturing process of the active ingredient in ALZ-101 – a vaccine in clinical development for the treatment of Alzheimer’s disease. Process optimisations have resulted in a more efficient and scalable manufacturing

Aker ASA: Annual Report, Corporate Governance and Sustainability Reports for 2021

Aker ASA hereby publishes its Annual Report for 2021 including the Corporate Governance Report, and its Sustainability Report for 2021. The reports are attached and available on www.akerasa.comAker ASA has also published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release. -ENDS- For more information, please contact: Investors:Joachim Bjørni, Head of Investor Relations, Aker ASATel: +47 924 22 106E-mail: joachim.bjorni@akerasa.com Media:Atle Kigen, Head of Media Relations and Public Affairs, Aker ASA

There are no items matching the current filter
There are no more items matching the current filter
Back to top